DoD Says AVI Biopharma's (AVII) Flu Drug Candidate Does Not Qualify for Contract Award
AVI Biopharma (Nasdaq: AVII) receives notice from Department of Defense its proposal for full clinical development of its influenza candidate, AVI-7100 did not qualify for a contract award.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cheniere Energy (LNG), EDP Sign 20-Year LNG Sale and Purchase Agreement
- Kandi Technologies Group (KNDI) Unit Signs Contract for Sale of 700 Kandi-Branded EVs
- UPDATE: 21st Century Fox (FOXA) to Acquire Video Ad Company, true[X] Media
Create E-mail Alert Related CategoriesCorporate News
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!